Skip to main content
Marylyn M. Addo on Muck Rack

Marylyn M. Addo

As seen in: Nature, Wiley Online Library, MDPI, Stern
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Marylyn M.

Contact Marylyn M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition - npj Vaccines

|
By Claudia Fischer, Edith Willscher, Bianca Klee, Jochen Dutzmann, Matthias Girndt, Marylyn M. Addo, Mascha Binder
| Nature Verified
Abstract The rapid development of safe and effective vaccines helped to prevent severe disease courses after SARS-CoV-2 infection and to mitigate the progression of the COVID-19 pandemic. While there is evidence that vaccination may reduce the risk of developing post-COVID-19 conditions (PCC), this effect may depend on the viral variant. Therapeutic effects of post-infection vaccination have been discussed but the data for individuals with PCC remains inconclusive.
Open in Who Shared Issue with article?

Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease - Communications Medicine

|
By Katrin Hufnagel, Anahita Fathi, Ramy Girgis, Jörg D. Hoheisel, Marylyn M. Addo
| Nature Verified
Abstract Background The clinical course of COVID-19 patients ranges from asymptomatic infection, via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which enable an early prediction of the severity of COVID-19 progression, would be enormously beneficial to guide patient care and early intervention prior to hospitalization.
Open in Who Shared View Duplicates (2) Issue with article?

Higher Risk of HEV Transmission and Exposure among Blood Donors in Europe and Asia in Comparison to North America: A Meta-Analysis

|
By Sven Pischke, Ann-Kathrin Ozga, Marylyn M. Addo, Annika Wolski
| MDPI
1. Introduction Globally, hepatitis E is the most common cause of enterically transmitted hepatitis [1]. Anti-HEV IgG seroprevalence rates of 18% up to 30% were reported in the Netherlands and Germany in 2013, and even higher rates of over 50% were reported in some areas of France [2]. In humans, genotypes 1–4 are of the highest relevance. Genotypes 1 and 2 exclusively infect humans and are endemic in tropical areas, such as Asia, the south of Africa, and parts of Central America.
Open in Who Shared Issue with article?
See all 10 articles